Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

DIA Innovation Forum to Highlight Latest Initiatives in Research & Development in the EU

The Drug Information Association (DIA) will host the first Innovation Forum (http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16917&eventType=Meeting) (29-30 September; London, UK).

Basel, Switzerland (PRWEB) August 12, 2008 -- The Drug Information Association (DIA) will host the first Innovation Forum (http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16917&eventType=Meeting) (29-30 September; London, UK). This brand new conference will feature experts from the European Medicines Agency (EMEA), the Committee for Medicinal Products for Human Use (CHMP), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Commission, European Biopharmaceutical Enterprises (EBE), EuropaBio, Eucomed and senior industry representatives.

Session topics will include:

•    Innovation in Europe - Future Challenges

•    Innovative Medicines Initiative

•    Qualification of Biomarkers and Novel Methodologies

•    Role of EMEA in Relation to Innovation

•    EU Commission and EMEA Implementation

•    EU Commission and EMEA Implementing Technical Requirements

•    Risk Management, Pharmacovigilance and Traceability

•    GMP and GCP Issues

Participants will be briefed on the latest initiatives in Europe to support innovation in research and development and will be able to share the FDA experience with the implementation of the Critical Path Initiative and coordination with the EU initiatives. The conference will provide a platform to discuss the implementation of the European Parliament and Council Regulation on Advanced Therapy and the EMEA draft technical guidelines.

About the Drug Information Association (DIA) (http://www.diahome.org/)

The Drug Information Association serves more than 30,000 professionals in the biotechnology and pharmaceutical industries, regulatory agencies, contract research and patient organisations worldwide. Through its domestic and international meetings, training courses, workshops and webinars, the DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:

Joe Krasowski

+1 215-293-5812

Joe.Krasowski @ diahome.org

# # #

Simillar Articles

20th Annual DIA EuroMeeting "Shifts One Gear Up"
The Drug Information Association (DIA) will celebrate the 20th Anniversary of the EuroMeeting in Barcelona, Spain, from March 3-5, 2008. New Format includes 11 Themes, 350 Speakers and...
Xcelience Completes Successful QP Audit of Production Facility for European Market
Xcelience achives its third successful audit.
New Article on Protecting Intellectual Property & Regulatory Compliance Released
Cerulean Associates LLC (http://www.ceruleanllc.com/) is honored to announce the publication of its article on how biotechnology firms, pharmaceutical companies and research and development...
Producers of Pharmaceutical Packaging Forum Announce Cooperative Agreement with Ipack-Ima Spa
Owners on opposite sides of the world agree to help each other grow their pharmaceutical packaging events. Pharmaceutical Packaging Forum, owned by Chicago publisher Summit Publishing Company, and...
AB Science S.A. Announces European Marketing Authorization of Novel Veterinary Oncology Drug;...
AB Science S.A., a biotechnology company that is focused on the development of novel and targeted drugs for cancer, inflammatory disease, and neurological disorders, today announced the recent...
Home Terms of Use Privacy Policy Contact Us